David R. Axline, MD, FACC

Heroic save following AMI Shock in a patient with double insult: ventricular pseudoaneurysm and VRS. #innovation #heartteam @NCHRooneyHeart @JACCJournals #Shock #AMI @ACCinTouch @JACCJournals @DeeDeeWangMD @PU84 @DrBrianSolomon sciencedirect.com/science/articl…

NCH Rooney Heart Institute continues to lead- welcome Dr. Lamelas! @RCubedduMD @NCHRooneyHeart @JosephLamelas

NCH Rooney Heart Institute is the first in Florida to offer Abbott’s new MitraClip™ & TriClip™ G5 system—giving high-risk patients with “leaky” heart valves a minimally invasive option to improve symptoms & quality of life. 📄 Read more: bit.ly/45KzhhZ

Is atrial remodeling after AFib catheter ablation a game-changer for heart health? New insights raise the question: How clinically relevant is this process for long-term outcomes? Read more in #EHJ. doi.org/10.1093/eurhea… #cardiotwitter @ESC_Journals @escardio.

@crowanmd Available right now for anyone/everyone with prescriptions, including Medicare w/o part D, uninsured, high copays, prior authorizations denied… This is the self pay, cash price for 30 day supply mail order ARNI $62.50 MRA $6.44 BB $6.32 SGLT2i $49.85 costplusdrugs.com

Documentation: ARNI+BB+MRA+SGLT2i Cash price, 30 day supply $121.11 Please note standard shipping costs of $5 not included

Growing evidence demonstrates that a lower systolic blood pressure of <120 mm Hg significantly reduces #ASCVD risk for patients at high risk. Check out the expert analysis to learn more ➡️ bit.ly/3I7jbXm #cvPrev

Today, we broke ground on the RM Schulze Family Heart & Stroke Critical Care Center — future home of the @NCHRooneyHeart & NCH Wingard Stroke Institute. This innovative center will bring together world-class cardiac, vascular, and stroke care under one roof, right here in SWFL.

🎯

TAVR for patients with Aortic Regurgitation (AR). Now available. Actively enrolling in the JOURNEY clinical trial @NCHRooneyHeart @NCHFlorida For more information please call 239-624-8387

An excellent expert consensus document on statins in geriatrics. Also advocates for CAC scanning to help decision making (IIa recommendation). i am a strong advocate of treating older active adults with statins agsjournals.onlinelibrary.wiley.com/doi/full/10.11…

World Premiere: first commercially approved transseptal mitral valve at Universitätsmedizin Mainz - the SAPIEN M3 TMVR - many more patients in the future. 🚀#PCR Mitral Focus Group @vonBardelebenRS @AGIKinterv @DGK_org @EZancanaroMD @KardiologieHH @ESC_Journals @thiele_holger

This #JACCINT retrospective, multicenter, observational study suggests that #SGLT2i may slow the progression of non-severe aortic stenosis! Check out the full paper here: jacc.org/doi/10.1016/j.… #vhdAS

Worth posting again. “Healthcare”

@musk_news13 Yes

A new twin study has strengthened the link between tattoos and cancer risk. For tattoos larger than a palm: 🔺 137% higher risk of skin cancer (HR = 2.37) 🩸 173% higher risk of lymphoma (HR = 2.73) Let’s break it down 🧵 1/11

According to an updated meta-analysis including 6 RCTs and 5,341 low-risk patients, #TAVR was associated with a reduced hazard of death and death or disabling stroke compared with #SAVR, while rates of stroke were equivalent jacc.org/doi/10.1016/j.… @JACCJournals

Long-term treatment with finerenone is estimated to extend event-free survival by up to 3 years among people with HF with mildly reduced or preserved ejection fraction. ja.ma/4i9tO8Q @mvaduganathan

#SGLT2 inhibitors may slow the progression of nonsevere aortic stenosis, according to a study published in #JACCINT. Learn more: bit.ly/4hOrOmA #vhdAS #cvVHD @JACCJournals

BKING NEWS! announcing the arrival of Thomas G. Caranasos MD as the new J. Yeh Endowed Chair of CardioThor Surg & VP of Rooney Heart Institute, bringing vast experience to SWFL in complex valve ds, aortopathies & advanced HF @tommycaranasos @AATSHQ @STS_CTsurgery @NCHRooneyHeart